Small molecule therapeutics that mimic the action of carbohydrates to treat inflammatory and infectious diseases
- Year invested 2003
- Investment Stage Early
- Sectors
- Investment Status Current
- Website glycomimetics.com
- Company Status IPO/Public (NASDAQ: GLYC)